Skip to main content

United States News All stories

Every story in this section, newest first — page 230 of 373.

Grafa
Insights

Why Wall Street just pulled the plug on crypto

For a fleeting moment last autumn, it appeared that the long-running friction between the frantic world of cryptocurrency and the buttoned-down halls of global finance had finally reached a grand synthesis. 

With the debut of spot exchange-traded funds (ETFs) and Bitcoin scaling heights near $126,000, the industry’s boosters declared that "digital gold" had finally arrived as a permanent fixture of the modern portfolio.

Read more: Why Wall Street just pulled the plug on crypto
Grafa
Technology

Applied Digital posts triple-digit revenue growth as AI infrastructure demand scales

Applied Digital (NASDAQ:APLD), a designer and operator of next-generation digital infrastructure for high-performance computing (HPC) and artificial intelligence, reported a 139% year-over-year revenue increase for its third fiscal quarter of 2026 on April 8, 2026.

Read more: Applied Digital posts triple-digit revenue growth as AI infrastructure demand scales
Grafa
Technology

PriceSmart surpasses $1.5B in quarterly revenue, announces new expansion in Guatemala

PriceSmart (NASDAQ:PSMT), the largest operator of membership warehouse clubs in Central America, the Caribbean, and Colombia, reported robust financial results for its second fiscal quarter ended February 28, 2026, on April 8, 2026.

Read more: PriceSmart surpasses $1.5B in quarterly revenue, announces new expansion in Guatemala
Grafa
Energy

Wallbox formalizes restructuring plan and secures €11M in interim liquidity

Wallbox (NYSE:WBX), a global leader in electric vehicle (EV) charging and energy management solutions, announced on April 8, 2026, that it has signed a definitive restructuring plan and related agreements to stabilize its capital structure and support its long-term business strategy.

Read more: Wallbox formalizes restructuring plan and secures €11M in interim liquidity
Grafa

TOMI Environmental solutions posts strong sequential revenue Growth in preliminary Q1 results

TOMI Environmental Solutions (NASDAQ:TOMZ), a global provider of disinfection and decontamination essentials, announced preliminary unaudited financial results for the first quarter of 2026 on April 8, highlighting a 67% sequential revenue increase over the fourth quarter of 2025.

Read more: TOMI Environmental solutions posts strong sequential revenue Growth in preliminary Q1 results
Grafa
Technology

SEALSQ posts 200% revenue increase in Q1, reaffirms bullish FY growth outlook

SEALSQ (NASDAQ:LAES), a developer of specialized semiconductors and post-quantum technology, announced preliminary financial results for the first quarter of 2026 on April 8, featuring a triple-digit revenue surge and a substantial expansion of its cash reserves.

Read more: SEALSQ posts 200% revenue increase in Q1, reaffirms bullish FY growth outlook
Grafa
Manufacturing

Virco reports full-year profitability amid strong incoming order rates

Virco (NASDAQ:VIRC), the domestic manufacturer and supplier of furniture and equipment for the education market, reported full-year financial results for the fiscal year ended January 31, 2026, characterized by steady annual earnings and a robust liquidity position.

Read more: Virco reports full-year profitability amid strong incoming order rates
Grafa
Industrials

Atkore divests HDPE pipe business to Infra Pipes in strategic portfolio realignment

Atkore (NYSE:ATKR) announced on April 8, 2026, the sale of its High-Density Polyethylene (HDPE) pipe and conduit business to Infra Pipes, a prominent North American manufacturer of polyethylene pipeline solutions.

Read more: Atkore divests HDPE pipe business to Infra Pipes in strategic portfolio realignment
Grafa

Adagio Medical secures FDA nod to expand clinical trial for next-gen VT ablation system

Adagio Medical Holdings (NASDAQ:ADGM) announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval to expand its FULCRUM-VT clinical trial.

Read more: Adagio Medical secures FDA nod to expand clinical trial for next-gen VT ablation system
Grafa
Mining

Odyssey Marine and AOMC announce $1B merger to create deep-sea minerals leader

Odyssey Marine Exploration (NASDAQ:OMEX) and American Ocean Minerals announced on April 8, 2026, that they have entered into a definitive merger agreement to combine their businesses, creating a premier platform for deep-sea critical minerals research and resource extraction.

Read more: Odyssey Marine and AOMC announce $1B merger to create deep-sea minerals leader
Grafa

Ontario court of appeal dismisses lawsuit against Barrick over North Mara mine

Barrick Gold (NYSE:B) welcomed a decisive legal victory on April 8, 2026, as the Ontario Court of Appeal dismissed an appeal brought by a group of Tanzanian residents concerning alleged human rights incidents near the North Mara gold mine.

Read more: Ontario court of appeal dismisses lawsuit against Barrick over North Mara mine
Grafa

FDA grants orphan drug designation to Plus Therapeutics’ REYOBIQ

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to REYOBIQ™ (rhenium Re186 obisbemeda).

Read more: FDA grants orphan drug designation to Plus Therapeutics’ REYOBIQ
Grafa

Bausch + Lomb secures FDA clearance for advanced vitrectomy technology

Bausch + Lomb (NYSE:BLCO), a leader in eye health, announced on April 8, 2026, that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Bi-Blade+ dual-port vitrectomy cutter and an advanced Adaptive Fluidics update for the Stellaris Elite® Vision Enhancement System.

Read more: Bausch + Lomb secures FDA clearance for advanced vitrectomy technology
Grafa

FDA grants breakthrough RMAT designation to United Therapeutics’ bioengineered liver assist product

United Therapeutics (NASDAQ:UTHR), a leader in regenerative medicine and organ manufacturing, announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational miroliverELAP®.

Read more: FDA grants breakthrough RMAT designation to United Therapeutics’ bioengineered liver assist product